Healthcare >> CEO Interviews >> August 14, 2000
JOSEPH C. COOK, JR., has been Chairman of the Board and Chief Executive
Officer of Amylin Pharmaceuticals, Inc., since March 1998. Prior to
that, he had served as a Board member of, and a consultant to, the
company from 1994. Mr. Cook serves as a member of the Board of Directors
of Boehringer Ingelheim Corporation US. Mr. Cook is a Founder and serves
as Chairman of the Board of Microbia, Inc., a privately held
biotechnology company. Mr. Cook is also a founder of Clinical Products,
Ltd., Life Science Advisors, LLC, Cambrian Associates, LLC, and Mountain
Ventures, Inc. Mr. Cook also serves on the Boards of the American
Diabetes Research Foundation, the Advisory Board of the College of
Engineering, University of Tennessee and the Board of Trustees for
Louisville Presbyterian Theological Seminary. Mr. Cook retired as a
Group Vice President of Eli Lilly & Company in 1993 after more than 28
years of service. Mr. Cook received a BS in Engineering from the
University of Tennessee. Profile
including a short history, the firm's origins, development, markets and
a bit of your own experience with the company.
Mr. Cook:
